Background: In 2009, the Institute of Medicine published revised gestational weight gain (GWG) guidelines with changes notable for altered body mass index (BMI) categorization as per World Health Organization criteria and a stated range of recommended gain (11-20 pounds) for obese women. The goal of this study was to evaluate associations between maternal BMI-specific GWG adherence in the context of these new guidelines and risk of small for gestational age (SGA) and large for gestational age (LGA) neonates. Methods: Subjects were a retrospective cohort of 11,203 live birth singletons delivered at 22-44 weeks at a Massachusetts tertiary care center between April 2006 and March 2010. Primary exposure was GWG adherence (inadequate, appropriate, or excessive) based on BMI-specific recommendations. SGA and LGA were defined as < 10th and ‡ 90th percentiles of U.S. population growth curves, respectively. The association between GWG adherence and SGA and LGA was examined in polytomous logistic regression models that estimated adjusted odds ratios (AOR) stratified by prepregnancy weight status, controlling for potential confounders. Results: Before pregnancy, 3.8% of women were underweight, 50.9% were normal weight, 24.6% were overweight, and 20.6% were obese. Seventeen percent had inadequate GWG, and 57.2% had excessive GWG. Neonates were 9.6% SGA and 8.7%
Introduction

B
oth small for gestational age (SGA) and large for gestational age (LGA) neonates are at considerable immediate and long-term health risk. SGA neonates are at risk for low Apgar scores, meconium aspiration, seizures, respiratory complications, extended hospital stays, and long-term sequelae, including metabolic syndrome and neurologic deficits. 1, 2 LGA neonates are at risk for cardiac anomalies, neural tube defects, shoulder dystocia, cesarean delivery, intrauterine fetal demise, neonatal intensive care unit (NICU) admissions, and long-term obesity. [2] [3] [4] [5] Both prepregnancy body mass index (BMI) and gestational weight gain (GWG) outside of recommended ranges are associated with SGA and LGA neonates. Overweight and obese women are at increased and decreased risks for LGA and SGA neonates, respectively. 6 Regardless of prepregnancy weight status, women who gain excessively during pregnancy are more likely to have macrosomic infants. [1] [2] [3] [4] For normal weight women, GWG below and above 1990 Institute of Medicine (IOM) recommendations is associated with increased risk of SGA and LGA neonates, respectively. 7 However, considering that 50% of pregnancies are unintended, 8 for the vast majority of women, GWG is the only weight parameter that is modifiable once prenatal care and associated counseling are initiated.
In May 2009, the IOM published new recommendations with regard to weight gain in pregnancy. 9 The revised guidelines are notable for two changes: (1) underweight, normal weight, overweight, and obese BMI categories were changed from the Metropolitan Life Insurance Table to World Health Organization (WHO) cutoff points, 9 and (2) obese women were provided with a range of recommended gain (11-20 pounds) 9 compared to the prior recommendation of ''at least 15 pounds'' with an unbounded upper limit. 10 Previous studies investigating associations of GWG with risk of SGA and LGA neonates have done so in the context of 1990 IOM GWG guidelines; only the recent publication by Margerison Zilko et al. 11 puts this important issue in the context of the updated guidelines. The goal of this study was to estimate the association between adherence to the revised 2009 IOM prepregnancy BMI-specific GWG recommendations and the occurrence of SGA or LGA neonates.
Materials and Methods
The University of Massachusetts Medical School's clinical partner, UMass Memorial Health Care's (UMMHC) automated electronic Labor & Delivery (L&D EMR) export database provided data for this retrospective cohort study. The initial cohort consisted of > 16,000 women who delivered singleton, live birth, nonanomalous neonates between April 1, 2006, and March 31, 2010 (Fig. 1) . Neonates with congenital anomalies as designated within the complications section of the delivery record were excluded. Women without recorded maternal prepregnancy weight, height, or documented GWG were excluded. Women with missing or unknown demographics of interest (marital status, smoking status, maternal age, parity, and race) were excluded. Women delivering at unknown gestational age, at < 22 weeks or > 44 weeks, or who delivered a neonate with unknown gender or with unknown birth weight were also excluded. Finally, for women with more than one pregnancy during the study period, one pregnancy was randomly selected for inclusion in analyses. Our final sample included 11,203 women and their neonates (Fig. 1) . The export database is surveyed periodically to evaluate internal consistency by direct comparison with patient charts. Variables missing information or data outliers were verified or corrected by chart review where possible. The UMMS Institutional Review Board approved this study.
Prepregnancy weight status was assessed with BMI (kilogram/meter 2 ) calculated from prepregnancy weight and height. Height in the L&D EMR was either obtained from the prenatal record or self-reported at time of delivery. Prepregnancy weight was recorded in the L&D EMR. L&D nurses were instructed to record prepregnancy weight according to a prioritized sequence as available: (1) self-reported prepregnancy weight as recorded in the woman's prenatal record, (2) weight self-reported by the women upon admission for delivery, or (3) Similar to prepregnancy weight, GWG was ascertained in L&D EMR through one of two sources per availability: (1) selfreport at time of delivery admission or (2) documented weight at last prenatal visit subtracted from prepregnancy weight in prenatal records. GWG was categorized as inadequate, appropriate, or excessive based on the IOM's 2009 prepregnancy BMI-specific GWG guidelines. Appropriateness of women's GWG was categorized using recommended GWG corresponding to individual gestational age at delivery, thus allowing for inclusion of preterm deliveries in addition to fullterm deliveries. To account for gestational age at delivery, minimum and maximum recommended gains at each week of gestational age were determined using IOM recommendations of gain by the end of the first trimester (week 13) and trajectory of gain throughout the second and third trimesters, assuming the following ranges of gain achieved by the 40th week: 28-40 pounds for women who were underweight before pregnancy, 25-35 pounds for women of normal weight, 15-25 pounds for overweight women, and 11-20 pounds for obese women. 9 Neonates were considered to be SGA and LGA, respectively, if birth weight was < 10th 12 and ‡ 90th 13 percentile of 1999-2000 U.S. national reference data 14 for singletons, accounting for gestational age and gender.
11 Gestational age at delivery was based on best dates for estimated date of confinement as per clinician evaluation and as recorded in L&D EMR.
Other characteristics abstracted from the L&D EMR and considered as covariates were (1) maternal age ( £ 19 years, 20-24 years, 25-39 years, 30-34 years, ‡ 35 years), (2) marital status (married vs. unmarried, including single, divorced, widowed, and separated), (3) ever smoker, which included smoking before or any time during pregnancy, (4) parity (nulliparous, primiparous, multiparous), (5) race/ethnicity representing either self-reported or attributed race/ethnicity (white, Hispanic, black, Asian, other race/ethnicity), (6) hypertension diagnosis (prepregnancy or pregnancy-associated hypertension diagnosis vs. absence of any hypertensive disease diagnosis), and (7) diabetes status (pregestational or gestational diabetes mellitus [GDM] diagnosis vs. absence of any diabetes diagnosis).
Statistical analyses
Demographic summary statistics are presented as either mean -standard deviation (SD) for continuous variables or as frequency measures for categorical variables. We initially included women of any prepregnancy weight status in our analyses and tested one-way interactions between covariates using chi-square tests. The interaction between prepregnancy weight status and adherence to GWG recommendations was statistically significant. Therefore, we stratified our analyses by prepregnancy weight status in order to make our results more easily interpreted in the context of providing useful and effective prenatal counseling.
We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for SGA and LGA in relation to adherence to GWG recommendations (GWG within recommended ranges compared to inadequate or excessive GWG), stratified by prepregnancy weight status, using polytomous logistic regression models. In polytomous logistic regression, the outcome takes one of three or more categories, and models are simultaneously fit using maximum likelihood to estimate ORs for each group compared to a common reference group. 15 We controlled for confounding using multivariate adjustment.
Covariates were considered for inclusion in the regression models based on previous research examining GWG and SGA/LGA, 1, 2, 4, 6, 7, 11, 16, 17 availability in the dataset, and significance on bivariate comparisons. We initially included in multivariate-adjusted models those covariates that were significantly related to appropriateness of neonatal size for gestational age category (SGA, appropriate for gestational age
[AGA], LGA) at p < 0.10 within strata of prepregnancy BMI. Adjusted models revealed significant correlation of age with parity or marital status on SGA, AGA, and LGA categories; thus, age was not included in the final adjusted models.
We also performed sensitivity analyses through examination of several other models. For women < 20 years of age at delivery, we calculated age-specific and gender-specific BMI percentiles and defined BMI categories according to the LGA, large for gestational age; SGA, small for gestational age.
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Centers for Disease Control and Prevention (CDC) definitions for children: underweight (< 5th percentile), healthy weight ( ‡ 5th and < 85th percentile), overweight ( ‡ 85th and < 95th percentile), and obese ( ‡ 95th percentile). 18 For these analyses, at risk of overweight was considered overweight, and overweight was considered obese with regard to consideration of recommended GWG ranges. We additionally examined models in which adolescents were excluded. As the definitions of SGA and LGA are percentiles based on population growth curves, and as infant birth weights have changed over time, models using different U.S. national reference data, 19 controlling for gender, were considered. Models in which mothers with diabetes or hypertension were excluded from analyses were evaluated because the relationship between these conditions and GWG is complex and may be on the causal pathway; for example, women with GDM may have lower GWG as a result of interventions for their diabetes. Additionally, this dataset does not adequately allow for distinction between pregestational and gestational diagnoses regarding these disease processes. Finally, preterm deliveries were excluded in one set of models, as reference cutoff points for SGA and LGA are less reliably measured by fetal growth reference population curves because preterm births are biased by a significant portion of preterm neonates being growth restricted. Analyses were performed using SAS (version 9.2, SAS Institute Inc., Cary, NC) statistical analysis software.
Results
Before pregnancy, 3.8% of women were underweight, 50.9% were normal weight, 24.6% were overweight, and 20.6% were obese. Nearly 75% of women gained outside of the ranges recommended by the IOM (17.0% gained inadequately and 57.2% gained excessively). Women were predominantly white (63.5%), married (60.1%), multiparous (58.6%), and nonsmokers (87.5%). Women were, on average, aged 29.0 ( -6.1) years. The most common comorbidities were pregestational diabetes or GDM (6.2%) and pregestational or pregnancy-related hypertensive disease (8%). Women were delivered at a mean gestational age of 38.9 ( -2.3) weeks, and their neonates had mean birth weights of 3310.5 ( -620.0) g. Approximately one tenth of neonates were SGA (9.6%, n = 1073), and 8.7% were LGA (n = 970). Table 1 displays demographics specific to combined BMI and GWG adherence categories. Within each BMI category, when progressing from inadequate to appropriate to excessive gain, infant birth weight increased (Table 1 ). In each BMI category, frequency of hypertensive disease diagnoses was highest among women who gained excessively, and frequency of preterm delivery was highest among women who gained inadequately (Table 1) .
Within BMI categories, when progressing from inadequate to appropriate to excessive gain, frequency of SGA decreased and frequency of LGA increased, respectively (Fig. 2) . Regardless of prepregnancy weight status, frequency of SGA was lower with higher GWG; additionally, frequency of LGA was higher among women of higher prepregnancy BMI who experienced greater weight gain. Underweight women with inadequate GWG had the highest frequency of SGA neonates. Obese women who gained excessively had the highest frequency of LGA neonates (Fig. 2) .
Inadequate GWG was associated with increased adjusted odds of SGA among underweight and normal weight women (Table 2) . Excessive GWG was associated with decreased adjusted odds of SGA among normal weight and overweight women, with trends for decreased odds in underweight and obese women. Inadequate GWG was associated with decreased adjusted odds of LGA among normal weight and obese women, with trends for decreased odds in overweight women. Excessive GWG was associated with increased adjusted odds of LGA among normal weight, overweight, and obese women, with trends for increased odds in underweight women. It should be noted that confidence intervals are likely wide in the underweight group because of relatively small numbers of women in this BMI category. The results of the various sensitivity analyses were very similar to those of the main analyses (data not shown).
Discussion
Inadequate GWG was associated with increased odds of SGA neonates, and excessive gain was associated with increased odds of LGA neonates. Conversely, inadequate gain was associated with decreased odds of LGA neonates, and excessive gain was associated with decreased odds SGA neonates. Using 1990 IOM guidelines, previous published studies have reported associations between maternal prepregnancy weight, 20 maternal BMI, 1, 21 and GWG 1, 17, 20 with fetal growth. A recent review of 35 studies found strong evidence supporting an association between excessive GWG and LGA and between inadequate GWG and SGA. 22 Our findings contribute to the limited information available on this topic specific to the new 2009 IOM GWG guidelines and thus describe the contemporary burden of growth-affected neonates born to women gaining outside of currently recommended GWG ranges. Margerison Zilko et al. 11 is the only other group to date to have published study findings based on the 2009 revised IOM guidelines for GWG and neonatal outcomes of SGA or LGA. In the current study, we found similar significant associations between adherence to GWG recommendations and SGA and LGA neonates, independent of maternal demographic and pregnancy characteristics. Margerison Zilko et al. 11 evaluated the odds of SGA and LGA by prepregnancy BMI and GWG adherence in separate adjusted models. Noting an interaction between BMI and GWG adherence, however, we presented our results stratified by maternal prepregnancy weight status, thus highlighting the increased risk of SGA and LGA in a manner directly relevant to provider counseling about GWG.
Two studies 20, 21 have reported increasing trends in LGA, and a third study reported decreased birth weight (mean 52 g) among all singleton term neonates in the U.S. between 1990 and 2005. 16 This last study additionally reported that LGA rates had decreased to 8.9%, consistent with our findings (8.7%), and reported stable SGA rates of approximately 10.2%. 16 In our study, approximately one tenth (9.6%) of neonates were SGA.
It should be noted that our cohort spans the change between the 1990 and 2009 guidelines. As the American College of Obstetricians and Gynecologists (ACOG) had not yet clearly endorsed the 2009 guidelines, counseling practices likely did not change in the transition period, and most women had already delivered or were pregnant when the IOM published its updated guidelines in 2009. Thus, the term ''adherence'' in this context most accurately describes these study conditions. In a previous study of this patient population, we found that counseling about GWG was limited even before guideline changes. 23 Although women in this study were likely not counseled about GWG using the 2009 guidelines, this study provides an estimate of the contemporary burden of SGA and LGA neonates associated with GWG outside the ranges newly recommended by the IOM.
With an expected normal distribution of birth weights, there will always be neonates who fall at the extremes, some of whom will be constitutionally healthy, whereas others will be pathologically affected. As clearly shown in Figure 2 , some groups of women are at significantly higher risk than expected for population burden of having an SGA or LGA neonate. Specifically, underweight women who gain inadequately (29.1%) and obese women who gain excessively (15.2%) are at significantly higher risk of delivering SGA and LGA neonates, respectively, than the expected 10%.
The strengths of our study include a cohort study design with a large sample of women derived from a clinical care database. This database availed us to examine comorbidities, thus allowing adjustment for underlying medical conditions, such as diabetes and hypertensive disease. Our study sample was drawn from the central Massachusetts region and PREGNANCY WEIGHT GAIN AND SGA/LGAincluded a patient population that is consistent with the 2008 Census Bureau's report of U.S. racial and ethnic composition. 24 Our study sample delivery dates ranged from 2006 to 2010 and were representative of the nation's epidemic of obesity, with one fifth of gravidas being obese. 25, 26 These characteristics of our sample potentially enhance the generalizability of our results to populations beyond those of central Massachusetts.
The use of a large clinical database facilitates examination of birth outcomes but has inherent limitations. Evaluation of covariates is limited by the absence of socioeconomic factors, such as education and poverty level. Further, the manner in which data were collected can cause unclear discernment between preexisting vs. gestational conditions (such as diabetes and hypertensive diseases) and, thus, has the potential to differentially affect results. For example, long-standing type 1 diabetes may be associated with vascular disease and SGA neonates, 27 whereas newly diagnosed GDM is more likely associated with LGA neonates. 28 A similar limitation was noted by Donahue et al. 16 when evaluating trends in birth weights in the United States. The association between these comorbidities and SGA or LGA is likely complex and potentially on the causal pathway; for example, weight gain is likely affected by clinical diabetes interventions. However, we performed sensitivity analyses excluding women with these comorbidities, and results were similar (data not shown). An additional limitation is that weight was not measured directly and was instead obtained from data entered into the L&D EMR by clinical nursing staff when women were in labor. The source of these values was either weight recalled at first prenatal visit or at delivery admission or weight measured at the first prenatal visit. Although a recommended order of prioritized data entry exists, we cannot confirm adherence to the recommended order. Recalled vs. measured weight has been shown by Brown et al. 29 to produce different results regarding effect of weight gain on newborn size.
Additionally, studies have found that underweight women tend to overestimate 30 and overweight women tend to underestimate 31 their prepregnancy weight, and women in this age group generally underestimate their weight and overestimate their heights, 32 potentially causing inaccurate classification of prepregnancy weight status and, thus, misclassified recommended GWG range. However, self-reported and clinically measured prepregnancy weights have been found to be highly correlated (r = 0.99) 33 and result in the same classification of prepregnancy weight status for 85% of women. 30 The proportion of women in our study population who were underweight before pregnancy was small in size compared to other populations, 26 and, thus, evaluation of this group was limited. Finally, we evaluated adherence by GWG at time of delivery as opposed to gain over specific trimesters or other parameters. Both total gain and rate of gain do not account for the fact that gain at specific pregnancy time points may be more influential on maternal and fetal outcomes, a concept that bears further consideration based on the current available literature. 29, [34] [35] [36] [37] [38] [39] [40] [41] [42] Conclusions BMI-specific GWG recommendations have been revised recently by the IOM, with the goal of optimizing maternal and neonatal immediate and long-term health outcomes. We found inadequate GWG to be significantly associated with increased odds of SGA for underweight and normal weight women. We also found excessive GWG to be significantly associated with increased odds of LGA for normal weight, overweight, and obese women. Thus, our findings support the updated guidelines with regard to the goal of optimizing birth of appropriate for gestational age neonatal weights. As weight gain during pregnancy is a modifiable factor associated with increased risk of SGA and LGA neonates, further counseling by providers is needed to help women attain guideline adherent weight gain during pregnancy. Further research and public health efforts should be focused on how to assist women in meeting these recommendations.
